Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1770 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sequenom Seals Licensing Agreement With Optherion

The license agreement covers intellectual property rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world. The portfolio of intellectual property being

PolyOne Enters Into Agreement With BASF

The company said that these high-temperature polymers can be used in applications such as respiratory devices, fluid collection containers and others that require optimum strength, chemical resistance and

Helix Medical Expands To Europe

Helix Medical Europe begins production this month at their newly built, 55,000 square foot facility located in Kaiserslautern, Germany. Initial manufacturing services will include custom molding of silicone

FDA Accepts Psyadon IND In LND Trial

The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3), with LND.

Novartis Gains Rights To Debio 025

As per the agreement, Novartis will make an upfront payment to Debiopharm, and the latter will be eligible for milestone payments and royalties on future sales of Debio

Troikaa Expects US Patent For Dyanapar AQ

Diclofenac injections are used for management of painful inflammatory conditions. Dynapar AQ is a high concentration, low viscosity injection of diclofenac sodium delivering the full therapeutic dose of